National Leiomyosarcoma Foundation
National Leiomyosarcoma Foundation maintains strong assets and zero liabilities with no reported officer compensation.
EIN: 141834266 · Denver, CO · NTEE: H123 · Updated: 2026-03-28
Is National Leiomyosarcoma Foundation Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
National Leiomyosarcoma Foundation directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About National Leiomyosarcoma Foundation
National Leiomyosarcoma Foundation (EIN: 141834266) is a nonprofit organization based in Denver, CO, classified under NTEE code H123. The organization reported total revenue of $181K and total assets of $453K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of National Leiomyosarcoma Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
National Leiomyosarcoma Foundation is a small nonprofit that has been operating for 24 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 11.8%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $258K |
| Total Expenses | $259K |
| Surplus / Deficit | $-1,823 |
| Total Assets | $463K |
| Net Assets | $463K |
| Operating Margin | -0.7% |
| Months of Reserves | 21.4 months |
Financial Health Grade: B
In 2023, National Leiomyosarcoma Foundation reported a deficit of $2K with expenses exceeding revenue, holds 21.4 months of operating reserves (strong position).
Financial Trends
Over 13 years of filings (2011–2023), National Leiomyosarcoma Foundation's revenue has grown at a compound annual growth rate (CAGR) of 11.8%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -2.7% | +92.8% | -0.4% |
| 2022 | +46.8% | +48.7% | +38.9% |
| 2021 | +39.8% | -25.9% | +36.7% |
| 2020 | +1.8% | +15.6% | +3.0% |
| 2019 | -19.7% | +8.0% | +10.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2002 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates National Leiomyosarcoma Foundation with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 5%
- programs: 90%
- fundraising: 5%
According to IRS 990 filings, National Leiomyosarcoma Foundation allocates its expenses as follows: admin: 5%, programs: 90%, fundraising: 5%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $2K, with expenses exceeding revenue.
Executive Compensation Analysis
The National Leiomyosarcoma Foundation consistently reports 0% officer compensation across all available filings, indicating that executive leadership is either unpaid or compensated through non-officer roles, which is highly favorable for directing funds towards its mission.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of National Leiomyosarcoma Foundation's IRS 990 filings:
- Expenses exceeded revenue in 2023 ($259,406 expenses vs. $257,583 revenue), though this was a minor deficit.
Strengths
The following positive indicators were identified for National Leiomyosarcoma Foundation:
- Consistent reporting of 0% officer compensation across all filings, maximizing funds for mission.
- Zero liabilities reported consistently, indicating strong financial health and no debt.
- Significant growth in assets from $201,151 in 2014 to $463,463 in 2023, demonstrating effective asset management.
- Consistent filing of IRS 990s over 13 periods, showing commitment to transparency and compliance.
- Substantial revenue growth over the past decade, indicating increasing donor support.
Frequently Asked Questions about National Leiomyosarcoma Foundation
Is National Leiomyosarcoma Foundation a legitimate charity?
Based on AI analysis of IRS 990 filings, National Leiomyosarcoma Foundation (EIN: 141834266) some concerns. Mission Score: 92/100. 1 red flag identified, 5 strengths noted.
How does National Leiomyosarcoma Foundation spend its money?
National Leiomyosarcoma Foundation directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to National Leiomyosarcoma Foundation tax-deductible?
National Leiomyosarcoma Foundation is registered as a tax-exempt nonprofit (EIN: 141834266). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Is the National Leiomyosarcoma Foundation financially stable?
Yes, the organization appears financially stable. It consistently reports zero liabilities and has grown its assets from $201,151 in 2014 to $463,463 in 2023, indicating a strong financial position.
How does the organization manage executive compensation?
The National Leiomyosarcoma Foundation reports 0% officer compensation in all available filings, suggesting that executive leadership is not compensated through traditional officer salaries, which is a positive for resource allocation.
Has the organization's revenue been consistent?
Revenue has shown growth over the long term, from $34,853 in 2015 to $257,583 in 2023, though there are year-to-year fluctuations, such as a slight decrease from $264,822 in 2022 to $257,583 in 2023.
Does the organization carry any debt?
No, the organization consistently reports $0 in liabilities across all available IRS 990 filings, indicating it operates without debt.
Filing History
IRS 990 filing history for National Leiomyosarcoma Foundation showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), National Leiomyosarcoma Foundation's revenue has grown by 282.8%, moving from $67K to $258K. Total assets increased by 186% over the same period, from $162K to $463K. Total functional expenses rose by 108.3%, from $125K to $259K. In its most recent filing year (2023), National Leiomyosarcoma Foundation reported a deficit of $2K, with expenses exceeding revenue.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $258K | $259K | $463K | $0 | — | — |
| 2022 | $265K | $135K | $465K | $0 | — | View 990 |
| 2021 | $180K | $90K | $335K | $0 | — | View 990 |
| 2020 | $129K | $122K | $245K | $0 | — | View 990 |
| 2019 | $127K | $106K | $238K | $0 | — | View 990 |
| 2018 | $158K | $98K | $216K | $0 | — | View 990 |
| 2017 | $98K | $97K | $111K | $0 | — | View 990 |
| 2016 | $88K | $164K | $114K | $0 | — | View 990 |
| 2015 | $35K | $47K | $189K | $0 | — | View 990 |
| 2014 | $66K | $33K | $201K | $0 | — | View 990 |
| 2013 | $56K | $108K | $168K | $0 | — | View 990 |
| 2012 | $143K | $69K | $221K | $0 | — | View 990 |
| 2011 | $67K | $125K | $162K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $258K, expenses of $259K, and assets of $463K (revenue -2.7% year-over-year).
- 2022: Revenue of $265K, expenses of $135K, and assets of $465K (revenue +46.8% year-over-year).
- 2021: Revenue of $180K, expenses of $90K, and assets of $335K (revenue +39.8% year-over-year).
- 2020: Revenue of $129K, expenses of $122K, and assets of $245K (revenue +1.8% year-over-year).
- 2019: Revenue of $127K, expenses of $106K, and assets of $238K (revenue -19.7% year-over-year).
- 2018: Revenue of $158K, expenses of $98K, and assets of $216K (revenue +60.6% year-over-year).
- 2017: Revenue of $98K, expenses of $97K, and assets of $111K (revenue +11.4% year-over-year).
- 2016: Revenue of $88K, expenses of $164K, and assets of $114K (revenue +153.4% year-over-year).
- 2015: Revenue of $35K, expenses of $47K, and assets of $189K (revenue -46.9% year-over-year).
- 2014: Revenue of $66K, expenses of $33K, and assets of $201K (revenue +17.7% year-over-year).
- 2013: Revenue of $56K, expenses of $108K, and assets of $168K (revenue -60.9% year-over-year).
- 2012: Revenue of $143K, expenses of $69K, and assets of $221K (revenue +112.0% year-over-year).
- 2011: Revenue of $67K, expenses of $125K, and assets of $162K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for National Leiomyosarcoma Foundation:
Data Sources and Methodology
This transparency report for National Leiomyosarcoma Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.